JYYS Granule Mitigates Renal Injury in Clinic and in Spontaneously Hypertensive Rats by Inhibiting NF-B Signaling-Mediated Microinflammation

Table 2

Effects of JYYS granule on the hemodynamic parameters of the renal artery in patients with hypertension-induced renal damage.

Indicators	Renal artery	treatment group (n=20)		placebo group (n=20)
		pre-therapy	post-treatment	pre-therapy	post-treatment
RI	Left	0.77±0.18	0.61±0.10^#@	0.78±0.17	0.70±0.14
	Right	0.77±0.21	0.60±0.09^#@	0.77±0.20	0.69±0.15
PI	Left	1.24±0.18	0.98±0.12	1.24±0.18	1.12±0.12
	Right	1.26±0.24	1.02±0.13	1.23±0.20	1.10±0.18
Vm (m/s)	Left	16.27±9.15	28.62±6.19^#@	17.53±9.75	20.74±7.58
	Right	17.15±8.95	26.27±6.64	16.84±9.27	21.47±7.23
Vdmin (m/s)	Left	9.67±3.73	14.27±4.12	10.12±3.46	12.73±4.68
	Right	10.04±4.62	15.93±4.87^@	9.89±4.01	12.59±4.44
Vsmax (m/s)	Left	26.74±6.67	35.27±6.99	27.47±5.78	30.98±5.94
	Right	28.09±6.98	36.42±7.01	28.43±6.26	32.79±7.05
AT (s)	Left	0.11±0.03	0.06±0.02	0.12±0.04	0.08±0.03
	Right	0.12±0.03	0.07±0.03	0.13±0.04	0.08±0.04

Abbreviation: RI (resistive index), PI (pulse index), AT (acceleration time), Vsmax (peak velocity of the systolic wave), Vdmin (minimum velocity of the diastolic stage), and Vm (mean velocity of the arterial blood). P<0.05, ^#P<0.01 versus pre-therapy in treatment group and placebo group; ^@P<0.05 versus post-treatment in placebo group.